AllianceBernstein
KZR

AllianceBernstein’s Kezar Life Sciences KZR Stock Holding History

AllianceBernstein’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,906
Closed -$71.3K – 3270
2024
Q1 		$71.3K Hold
7,906
– – ﹤0.01% 3060
2023
Q4 		$74.9K Sell
7,906
-860
-10% -$7.56K ﹤0.01% 3098
2023
Q3 		$104K Sell
8,766
-341
-4% -$6.04K ﹤0.01% 3060
2023
Q2 		$223K Buy
9,107
+2,348
+35% +$61.1K ﹤0.01% 2951
2023
Q1 		$212K Hold
6,759
– – ﹤0.01% 2886
2022
Q4 		$476K Buy
6,759
+690
+11% +$51.2K ﹤0.01% 2657
2022
Q3 		$523K Hold
6,069
– – ﹤0.01% 2630
2022
Q2 		$502K Sell
6,069
-24,870
-80% -$2.19M ﹤0.01% 2680
2022
Q1 		$5.14M Buy
30,939
+24,119
+354% +$3.46M ﹤0.01% 1565
2021
Q4 		$1.14M Sell
6,820
-950
-12% -$107K ﹤0.01% 2408
2021
Q3 		$671K Hold
7,770
– – ﹤0.01% 2647
2021
Q2 		$422K Buy
7,770
+150
+2% +$8.52K ﹤0.01% 2883
2021
Q1 		$454K Sell
7,620
-170
-2% -$9.94K ﹤0.01% 2698
2020
Q4 		$407K Hold
7,790
– – ﹤0.01% 2689
2020
Q3 		$377K Hold
7,790
– – ﹤0.01% 2682
2020
Q2 		$404K Buy
7,790
+6,080
+356% +$307K ﹤0.01% 2741
2020
Q1 		$75K Buy
1,710
+640
+60% +$26K ﹤0.01% 3010
2019
Q4 		$43K Hold
1,070
– – ﹤0.01% 3099
2019
Q3 		$35K Hold
1,070
– – ﹤0.01% 3141
2019
Q2 		$82K Buy
+1,070
New +$166K ﹤0.01% 3102

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

AllianceBernstein's KZR Position: Q2 2024 in Review

AllianceBernstein sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 7,906 shares — an estimated $71.3K sold.

AllianceBernstein first reported a position in KZR in Q2 2019 and held it in 20 quarters. The position peaked at $5.14M in Q1 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • AllianceBernstein reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 7,906 Kezar Life Sciences shares in Q2 2024, an estimated $71.3K.
  • AllianceBernstein first reported a position in Kezar Life Sciences in Q2 2019 and held it in 20 quarters.
  • AllianceBernstein's Kezar Life Sciences position peaked at $5.14M in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.